Authors
Loading...
Preclinical study reveals Sfrp2 as the primary paracrine mediator of cardiomyocyte survival after ischemic injury, highlighting Wnt signaling modulation as a therapeutic target for heart disease.
Mirotsou et al. (2007) studied this question.